← Leaderboards
William Brand Feldman
Brigham And Women'S Hospital
$876,598
Attributed
$1,275,787
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $665.7K · FY2023–25$1M$750K$500K$250K$0
'23
'24
'25
Funding mix
By agency
FDA$798,379 · 1
NIH$477,408 · 1
By mechanism
U01$798,379 · 1
K08$477,408 · 1
Top collaborators
- Shirley Wang2 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Krista F Huybrechts$10,039,261
- Brian Thomas Bateman$6,450,805
- Sebastian G. Schneeweiss$14,258,306
- Joshua K Lin$16,782,382
- Elisabetta Patorno$4,890,327
Others in their field
Other Rising Stars on “Activities Of Daily Living”
- Jennifer Lee O'Brien · University Of South Florida$15,110,862
- Jacob Sutton Coverstone · Neurovations$6,882,205
- Karen A. Stark · Digital Infuzion, Inc.$3,804,755
- Hailey Rose Banack · State University Of New York At Buffalo$3,615,603
- Marco Capogrosso · University Of Pittsburgh At Pittsburgh$3,027,117
- Sebastian Tong · University Of Washington$2,998,489
Research focus
Activities Of Daily LivingAdrenal Cortex HormonesAdherenceAlgorithmsAreaAuthorityAgonistAwardAzithromycinBiometryBudesonideCaringCause Of DeathCharacteristicsChronicChronic Obstructive Pulmonary DiseaseClinical PracticeClinical PredictorsClinical TrialsCodeComorbidityComparative EffectivenessComparative Effectiveness StudyComparative Safety
Grant awards (5)
The Safety of Switching Between Complex Branded and Generic Drugs: Developing a Semi-Automated Sequential Surveillance System Using Tree-Based Scan Statistics$499,957
U01 · FY2025 · FD
Improving COPD Outcomes: Using Real-World Data to Analyze Treatment Effectiveness, Safety, and Adherence$165,741
K08 · FY2025 · HL · contact PI
The Safety of Switching Between Complex Branded and Generic Drugs: Developing a Semi-Automated Sequential Surveillance System Using Tree-Based Scan Statistics$298,422
U01 · FY2024 · FD · contact PI
Improving COPD Outcomes: Using Real-World Data to Analyze Treatment Effectiveness, Safety, and Adherence$149,166
K08 · FY2024 · HL · contact PI
Improving COPD Outcomes: Using Real-World Data to Analyze Treatment Effectiveness, Safety, and Adherence$162,501
K08 · FY2023 · HL · contact PI